- Full Year 2023 Transgene SA Earnings Call TranscriptMar 27, 2024€1.08 (-0.55%)Earnings
- Half Year 2023 Transgene SA Earnings Call TranscriptSep 20, 2023€1.81 (+1.80%)Earnings
- Transgene SA Conference Call TranscriptMay 05, 2023
- Full Year 2022 Transgene SA Earnings Call TranscriptMar 16, 2023€1.91 (-1.55%)Earnings
- Transgene SA Interim Analysis of TG4001 Phase II Trial Call TranscriptNov 02, 2022
- Transgene SA R&D Day TranscriptSep 27, 2022
- Q2 2022 Transgene SA Earnings Call TranscriptSep 07, 2022€2.06 (+0.49%)Earnings
- Q4 2021 Transgene SA Earnings Call TranscriptMar 16, 2022€2.22 (+6.47%)Earnings
- Transgene SA Corporate Call TranscriptDec 15, 2021
- Transgene SA TG4050 Phase I Studies Results Webcast TranscriptNov 23, 2021
- Q2 2021 Transgene SA Earnings Call TranscriptSep 22, 2021€2.41 (+1.26%)Earnings
- Transgene SA Presents Results From the Phase 1b/2 trial of TG4001 in Combination with Avelumab Conference Call TranscriptNov 12, 2020
- Transgene SA Results from Clinical Study of TG4001 in Combination with Avelumab Conference Call TranscriptJul 22, 2020
- Q4 2019 Transgene SA Earnings Call TranscriptMar 11, 2020€1.23 (+6.59%)Earnings
Transgene SA Conference Call Transcript
Hello, and welcome to the Transgene conference call. My name is Ben, and I will be the coordinator for today's call. Please note, this call is being recorded. (Operator Instructions) I will now hand you over to your host, Lucie Larguier, Head of Investor Relations, to begin today's conference. Thank you.
Thank you, and hello, everyone. So I have the pleasure today to introduce you to Dr. Alessandro Riva, who has just been appointed Chairman and CEO, Transgene, along with Hedi Ben Brahim, we will review today's news and answer your questions. Before I turn the call over to Alessandro Riva, I'd like to remind everyone that today's discussion contains forward-looking statements, which are subject to numerous risks and uncertainties. If you're listening to this webcast on the Internet, you will not be able to ask questions. If you wish to ask questions, please make sure that you join us via one of the conference call numbers that are available in today's press release. With this, I now turn
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)